Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.
Identifieur interne : 001884 ( PubMed/Curation ); précédent : 001883; suivant : 001885Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.
Auteurs : Takumi Yamamoto [Japon] ; Mitsunaga Narushima ; Hidehiko Yoshimatsu ; Nana Yamamoto ; Aiko Oka ; Yukio Seki ; Takeshi Todokoro ; Takuya Iida ; Isao KoshimaSource :
- Annals of plastic surgery [ 1536-3708 ] ; 2013.
Descripteurs français
- KwdFr :
- Colorants fluorescents (administration et posologie), Colorants fluorescents (pharmacocinétique), Humains, Injections sous-cutanées, Jambe, Lymphoedème (imagerie diagnostique), Lymphoedème (métabolisme), Lymphoedème (étiologie), Lymphographie (), Noeuds lymphatiques (métabolisme), Tumeurs du bassin (), Tumeurs du bassin (imagerie diagnostique), Vaisseaux lymphatiques (imagerie diagnostique), Vert indocyanine (administration et posologie), Vert indocyanine (pharmacocinétique), Évaluation des risques, Évolution de la maladie.
- MESH :
- administration et posologie : Colorants fluorescents, Vert indocyanine.
- imagerie diagnostique : Lymphoedème, Tumeurs du bassin, Vaisseaux lymphatiques.
- métabolisme : Lymphoedème, Noeuds lymphatiques.
- pharmacocinétique : Colorants fluorescents, Vert indocyanine.
- étiologie : Lymphoedème.
- Humains, Injections sous-cutanées, Jambe, Lymphographie, Tumeurs du bassin, Évaluation des risques, Évolution de la maladie.
English descriptors
- KwdEn :
- Disease Progression, Fluorescent Dyes (administration & dosage), Fluorescent Dyes (pharmacokinetics), Humans, Indocyanine Green (administration & dosage), Indocyanine Green (pharmacokinetics), Injections, Subcutaneous, Leg, Lymph Nodes (metabolism), Lymphatic Vessels (diagnostic imaging), Lymphedema (diagnostic imaging), Lymphedema (etiology), Lymphedema (metabolism), Lymphography (methods), Pelvic Neoplasms (complications), Pelvic Neoplasms (diagnostic imaging), Risk Assessment.
- MESH :
- chemical , administration & dosage : Fluorescent Dyes, Indocyanine Green.
- chemical , pharmacokinetics : Fluorescent Dyes, Indocyanine Green.
- complications : Pelvic Neoplasms.
- diagnostic imaging : Lymphatic Vessels, Lymphedema, Pelvic Neoplasms.
- etiology : Lymphedema.
- metabolism : Lymph Nodes, Lymphedema.
- methods : Lymphography.
- Disease Progression, Humans, Injections, Subcutaneous, Leg, Risk Assessment.
Abstract
Lymph transportation capacity is a critical function maintaining fluid circulation. After pelvic cancer treatments, lymph obstruction at the pelvic region leads to abnormal lymph circulation, resulting in lymph pump dysfunction. Besides lymph circulation, lymph pump function is important for lymphedema evaluation. We assessed and analyzed lymph transportation capacity of secondary lower extremity lymphedema patients using indocyanine green (ICG) lymphography according to corresponding severity stage. Indocyanine green velocity and transit time could evaluate lymph pump function; ICG velocity decreases and transit time increases as the lymphedema severity stage progresses. Measurement of ICG velocity required 5 minutes after the dye injection, whereas that of transit time took more than 1 hour in severe cases. Indocyanine green velocity can be easily obtained and is recommended for evaluation of lymph pump function compared with transit time. Dynamic ICG lymphography, which evaluates both lymph pump function and circulation, plays an important role in comprehensive assessment of lymphedema pathophysiology.
DOI: 10.1097/SAP.0b013e318255168a
PubMed: 24126343
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001884
Links to Exploration step
pubmed:24126343Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.</title><author><name sortKey="Yamamoto, Takumi" sort="Yamamoto, Takumi" uniqKey="Yamamoto T" first="Takumi" last="Yamamoto">Takumi Yamamoto</name><affiliation wicri:level="1"><nlm:affiliation>From the Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>From the Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo</wicri:regionArea></affiliation></author><author><name sortKey="Narushima, Mitsunaga" sort="Narushima, Mitsunaga" uniqKey="Narushima M" first="Mitsunaga" last="Narushima">Mitsunaga Narushima</name></author><author><name sortKey="Yoshimatsu, Hidehiko" sort="Yoshimatsu, Hidehiko" uniqKey="Yoshimatsu H" first="Hidehiko" last="Yoshimatsu">Hidehiko Yoshimatsu</name></author><author><name sortKey="Yamamoto, Nana" sort="Yamamoto, Nana" uniqKey="Yamamoto N" first="Nana" last="Yamamoto">Nana Yamamoto</name></author><author><name sortKey="Oka, Aiko" sort="Oka, Aiko" uniqKey="Oka A" first="Aiko" last="Oka">Aiko Oka</name></author><author><name sortKey="Seki, Yukio" sort="Seki, Yukio" uniqKey="Seki Y" first="Yukio" last="Seki">Yukio Seki</name></author><author><name sortKey="Todokoro, Takeshi" sort="Todokoro, Takeshi" uniqKey="Todokoro T" first="Takeshi" last="Todokoro">Takeshi Todokoro</name></author><author><name sortKey="Iida, Takuya" sort="Iida, Takuya" uniqKey="Iida T" first="Takuya" last="Iida">Takuya Iida</name></author><author><name sortKey="Koshima, Isao" sort="Koshima, Isao" uniqKey="Koshima I" first="Isao" last="Koshima">Isao Koshima</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24126343</idno><idno type="pmid">24126343</idno><idno type="doi">10.1097/SAP.0b013e318255168a</idno><idno type="wicri:Area/PubMed/Corpus">001884</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001884</idno><idno type="wicri:Area/PubMed/Curation">001884</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001884</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.</title><author><name sortKey="Yamamoto, Takumi" sort="Yamamoto, Takumi" uniqKey="Yamamoto T" first="Takumi" last="Yamamoto">Takumi Yamamoto</name><affiliation wicri:level="1"><nlm:affiliation>From the Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>From the Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo</wicri:regionArea></affiliation></author><author><name sortKey="Narushima, Mitsunaga" sort="Narushima, Mitsunaga" uniqKey="Narushima M" first="Mitsunaga" last="Narushima">Mitsunaga Narushima</name></author><author><name sortKey="Yoshimatsu, Hidehiko" sort="Yoshimatsu, Hidehiko" uniqKey="Yoshimatsu H" first="Hidehiko" last="Yoshimatsu">Hidehiko Yoshimatsu</name></author><author><name sortKey="Yamamoto, Nana" sort="Yamamoto, Nana" uniqKey="Yamamoto N" first="Nana" last="Yamamoto">Nana Yamamoto</name></author><author><name sortKey="Oka, Aiko" sort="Oka, Aiko" uniqKey="Oka A" first="Aiko" last="Oka">Aiko Oka</name></author><author><name sortKey="Seki, Yukio" sort="Seki, Yukio" uniqKey="Seki Y" first="Yukio" last="Seki">Yukio Seki</name></author><author><name sortKey="Todokoro, Takeshi" sort="Todokoro, Takeshi" uniqKey="Todokoro T" first="Takeshi" last="Todokoro">Takeshi Todokoro</name></author><author><name sortKey="Iida, Takuya" sort="Iida, Takuya" uniqKey="Iida T" first="Takuya" last="Iida">Takuya Iida</name></author><author><name sortKey="Koshima, Isao" sort="Koshima, Isao" uniqKey="Koshima I" first="Isao" last="Koshima">Isao Koshima</name></author></analytic><series><title level="j">Annals of plastic surgery</title><idno type="eISSN">1536-3708</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Progression</term><term>Fluorescent Dyes (administration & dosage)</term><term>Fluorescent Dyes (pharmacokinetics)</term><term>Humans</term><term>Indocyanine Green (administration & dosage)</term><term>Indocyanine Green (pharmacokinetics)</term><term>Injections, Subcutaneous</term><term>Leg</term><term>Lymph Nodes (metabolism)</term><term>Lymphatic Vessels (diagnostic imaging)</term><term>Lymphedema (diagnostic imaging)</term><term>Lymphedema (etiology)</term><term>Lymphedema (metabolism)</term><term>Lymphography (methods)</term><term>Pelvic Neoplasms (complications)</term><term>Pelvic Neoplasms (diagnostic imaging)</term><term>Risk Assessment</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Colorants fluorescents (administration et posologie)</term><term>Colorants fluorescents (pharmacocinétique)</term><term>Humains</term><term>Injections sous-cutanées</term><term>Jambe</term><term>Lymphoedème (imagerie diagnostique)</term><term>Lymphoedème (métabolisme)</term><term>Lymphoedème (étiologie)</term><term>Lymphographie ()</term><term>Noeuds lymphatiques (métabolisme)</term><term>Tumeurs du bassin ()</term><term>Tumeurs du bassin (imagerie diagnostique)</term><term>Vaisseaux lymphatiques (imagerie diagnostique)</term><term>Vert indocyanine (administration et posologie)</term><term>Vert indocyanine (pharmacocinétique)</term><term>Évaluation des risques</term><term>Évolution de la maladie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Fluorescent Dyes</term><term>Indocyanine Green</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Fluorescent Dyes</term><term>Indocyanine Green</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Colorants fluorescents</term><term>Vert indocyanine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Pelvic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphatic Vessels</term><term>Lymphedema</term><term>Pelvic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Lymphoedème</term><term>Tumeurs du bassin</term><term>Vaisseaux lymphatiques</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lymph Nodes</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymphography</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Lymphoedème</term><term>Noeuds lymphatiques</term></keywords><keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Colorants fluorescents</term><term>Vert indocyanine</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term><term>Humans</term><term>Injections, Subcutaneous</term><term>Leg</term><term>Risk Assessment</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Injections sous-cutanées</term><term>Jambe</term><term>Lymphographie</term><term>Tumeurs du bassin</term><term>Évaluation des risques</term><term>Évolution de la maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymph transportation capacity is a critical function maintaining fluid circulation. After pelvic cancer treatments, lymph obstruction at the pelvic region leads to abnormal lymph circulation, resulting in lymph pump dysfunction. Besides lymph circulation, lymph pump function is important for lymphedema evaluation. We assessed and analyzed lymph transportation capacity of secondary lower extremity lymphedema patients using indocyanine green (ICG) lymphography according to corresponding severity stage. Indocyanine green velocity and transit time could evaluate lymph pump function; ICG velocity decreases and transit time increases as the lymphedema severity stage progresses. Measurement of ICG velocity required 5 minutes after the dye injection, whereas that of transit time took more than 1 hour in severe cases. Indocyanine green velocity can be easily obtained and is recommended for evaluation of lymph pump function compared with transit time. Dynamic ICG lymphography, which evaluates both lymph pump function and circulation, plays an important role in comprehensive assessment of lymphedema pathophysiology.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24126343</PMID><DateCreated><Year>2013</Year><Month>10</Month><Day>15</Day></DateCreated><DateCompleted><Year>2014</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of plastic surgery</Title><ISOAbbreviation>Ann Plast Surg</ISOAbbreviation></Journal><ArticleTitle>Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.</ArticleTitle><Pagination><MedlinePgn>591-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SAP.0b013e318255168a</ELocationID><Abstract><AbstractText>Lymph transportation capacity is a critical function maintaining fluid circulation. After pelvic cancer treatments, lymph obstruction at the pelvic region leads to abnormal lymph circulation, resulting in lymph pump dysfunction. Besides lymph circulation, lymph pump function is important for lymphedema evaluation. We assessed and analyzed lymph transportation capacity of secondary lower extremity lymphedema patients using indocyanine green (ICG) lymphography according to corresponding severity stage. Indocyanine green velocity and transit time could evaluate lymph pump function; ICG velocity decreases and transit time increases as the lymphedema severity stage progresses. Measurement of ICG velocity required 5 minutes after the dye injection, whereas that of transit time took more than 1 hour in severe cases. Indocyanine green velocity can be easily obtained and is recommended for evaluation of lymph pump function compared with transit time. Dynamic ICG lymphography, which evaluates both lymph pump function and circulation, plays an important role in comprehensive assessment of lymphedema pathophysiology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Takumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narushima</LastName><ForeName>Mitsunaga</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yoshimatsu</LastName><ForeName>Hidehiko</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Nana</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>Aiko</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Seki</LastName><ForeName>Yukio</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Todokoro</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Iida</LastName><ForeName>Takuya</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Koshima</LastName><ForeName>Isao</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Plast Surg</MedlineTA><NlmUniqueID>7805336</NlmUniqueID><ISSNLinking>0148-7043</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>IX6J1063HV</RegistryNumber><NameOfSubstance UI="D007208">Indocyanine Green</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007208" MajorTopicYN="N">Indocyanine Green</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007279" MajorTopicYN="N">Injections, Subcutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008220" MajorTopicYN="N">Lymphography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010386" MajorTopicYN="N">Pelvic Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24126343</ArticleId><ArticleId IdType="doi">10.1097/SAP.0b013e318255168a</ArticleId><ArticleId IdType="pii">00000637-201311000-00034</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001884 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001884 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24126343
|texte= Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24126343" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |